Release Date: 13/06/18 08:57 Summary: Announcement on behalf of Offeror Price Sensitive: Yes Download Document 240.36KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%